c-Met expression in tall cell variant papillary carcinoma of the thyroid

Cancer

Volumn 98, Issue 7, 2003, Pages 1386-1393

  Nardone, Heather C ^a   Ziober, Amy F ^a   LiVolsi, Virginia A ^a   Mandel, Susan J ^a   Baloch, Zubair W ^a   Weber, Randal S ^a   Mick, Rosemarie ^b   Ziober, Barry L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

c Met; Hepatocyte growth factor; Invasion; Papillary thyroid carcinoma; Tall cell variant

Indexed keywords

SCATTER FACTOR; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER INVASION; CANCER PATIENT; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC CODE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; MALE; ONCOGENE; ONCOGENE C MET; PRIORITY JOURNAL; SKELETAL MUSCLE; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID PAPILLARY CARCINOMA TALL CELL VARIANT;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; CULTURE TECHNIQUES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROBABILITY; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; THYROID DISEASES; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0141563730     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11638     Document Type: Article

References (29)

1. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251:802-804.
2. Giordano S, Ponzetto C, DiRenzo MF, Cooper CS, Comoglio PM. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature. 1989;339:155-156.
3. Gonzatti-Haces M, Seath A, Park M, Copeland T, Oroszlan S, Vande Wounde GF. Characterization of the trp-met oncogene p65 and the met protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci U S A. 1978;85:21-25.
4. Ponzetto C, Bardelli A, Zhen Z, et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 1994;77:261-271.
5. De Luca A, Arena N, Sena LM, Medico E. Met overexpression confers HGF-dependent invasive phenotype to human thyroid carcinoma cells in vitro. J Cell Physiol. 1999;180:365-371.
6. Di Renzo MF, Narsimhan RP, Olivero M, et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 1991;6:1997-2003.
7. Dremier S, Taton M, Coulonval K, Makamura T, Matsumoto K, Dumont JE. Mitogenic, dedifferentiating, and scattering effects of hepatocyte growth factor on dog thyroid cells. Endocrinology. 1994;135:135-140.
8. Rosen EM, Nigam SK, Goldberg I. Scatter factor and c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol. 1994;127:1783-1787.
9. Jeffers M, Rao MS, Rulong S, et al. Hepatocyte growth factor/scatter factor-met signaling induces proliferation, migration, and morphogenesis of pancreatic oval cells. Cell Growth Differ. 1996;7:1805-1813.
10. Scarpino S, Stoppacciaro A, Colarossi C, et al. Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid. J Pathol. 1999;189:570-575.
11. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990;111:2097-2108.
12. Di Renzo MF, Olivero M, Giacomini A, et al. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res. 1995;1:147-154.
13. Di Renzo MF, Olivero M, Katsaros D, et al. Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer. 1994;58:658-662.
14. Di Renzo MF, Poulsom M, Olivero M, Comoglio PM, Lemoine NR. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res. 1995;55:1129-1138.
15. Ichimura E, Maeshima A, Nakajima T, Nakamura T. Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance. Jpn J Cancer Res. 1996;87:1063-1069.
16. Natali PG, Prat M, Nicotra MR, et al. Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer. 1996;69:212-217.
17. Di Renzo MF, Olivero M, Fero S, et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene. 1992;7:2549-2553.
18. Giordano S, DiRenzo MF, Narsimhan RP, Cooper CS, Rosa C, Comoglio PM. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene. 1989;4:1383-1388.
19. Schlumberger MF. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338:297-306.
20. Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q. 1976;43:207-216.
21. Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 1988;12:22-27.
22. Ruco LP, Stoppacciaro A, Ballarini F, Prat M, Scarpino S. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. J Pathol. 2001;194:4-8.
23. Belfiore A, Gangemi P, Constantino A, et al. Negative/low expression of the met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab. 1997;82:2322-2328.
24. Zanetti A, Stoppacciaro A, Marzullo A, et al. Expression of met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. J Pathol. 1998;186:287-291.
25. Ramirez R, Hsu D, Patel A, et al. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin Endocrinol. 2000;53:635-644.
26. Lorenzato A, Olivero M, Patane S, et al. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res. 2002;62:7025-7030.
27. Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Expression of c-met is a strong independent prognostic indicator in breast carcinoma. Cancer. 1998;82:1513-1520.
28. Chen BK, Ohtsuki Y, Furihata M, et al. Overexpression of c-Met protein in human tumors correlated with lymph node metastases and clinicopathologic stage. Pathol Res Pract. 1999;195:427-433.
29. Ruco LP, Ranalli T, Marzullo A, et al. Expression of met protein in thyroid tumors. J Pathol. 1996;180:266-270.